UBS Raises C3.ai Price Target to $12

Analyst: Radi Sultan 1 min read Reproduced verbatim
Rating
Neutral
Target
$12
from $9 (+33%)
Outcome
Reached
on October 13, 2026
UBS and C3.ai logos

What the analyst said

UBS analyst Radi Sultan raised the price target on C3.ai (NYSE: AI) to $12.00 (from $9.00) while maintaining a Neutral rating.

“We’d characterize C3.ai’s F4Q26 results as mixed, while q/q revs declined again sequentially (-$1.7m) to $51.6m, the preliminary FY27 revs guide did come in modestly better than investors were expecting at $225m at the midpoint vs investors expecting a range of $200-210m.

The guidance implies continued q/q revs improvement throughout FY27 (when we pressed the company they cited improving pipeline & deal velocity) and we believe the company will likely return to growth in 2H27 albeit on a very easy comp (2H26 revs were down ~50% y/y).

As FY27 will likely be a noisy year given all the moving parts around the restructuring, GTM changes and the return of Tom Siebel as CEO we believe the key question for the stock will be what a return to “normalized” growth looks like (growth in FY28/29).

We leave our FY27/28 revs estimates relatively unchanged at $235m (-6% y/y)/$275m (+17% y/y) vs prior $232m/$273m but would note that the range of outcomes, particularly around FY28 remains wide in our view.

Without more visibility into many of the key growth drivers (license revs, Fed revs ramping, scope of the GTM changes) and the stock not cheap at ~5x our CY27E revs we prefer to remain on the sidelines for now and remain Neutral rated.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

AI trades at $11.69. The 3 analysts who set a target in the last 3 months range from $7 to $12.50, with a median of $12. This $12 target is in line with the median.

Since the note AI has moved +9% (from $10.71). 12-month window: day 157 of 365, closes on June 4, 2027.

Track record

This call✓ Target reached on October 13, 2026, 4 months after the note.

Firm track recordUBS: 81% of its 54 targets at least a year old were reached within 12 months (#9 of 26 firms). Accuracy ranking →

Earnings reactionOne of 6 notes after C3.ai’s Jun 3 results: 2 raised · 0 cut · 4 kept. See every call →

UBS on C3.ai

UBS price targets on C3.ai

4 calls from June 9, 2025 to October 12, 2026. The target went from $28 to $12 (−57%). The rating stayed Hold.

UBS targetAI share price
  1. October 12, 2026Kept the $12 targetHold$12
  2. June 4, 2026 This noteTarget raised from $9 (+33%)Hold$12
  3. February 26, 2026Target cut from $28 (−68%)Hold$9
  4. June 9, 2025Earliest call shownHold$28
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.